PROTEMBIS
ProtEmbo is designed to be a simple and reliable solution for one of the most feared complications during TAVR. The advent of transcatheter treatments for valvular heart disease has been a major revolution in the care of patients with disabilities or intercurrent illnesses that precluded undergoing stressful open cardiac surgical procedures. Nonetheless, in spite of ongoing improvements in TAVR procedures and outcomes, the occurrence of cerebrovascular events represents a significant morbidity ... of TAVR. Protembis was founded based on the vision to reduce the risk of cerebrovascular events, thereby improving outcomes and making TAVR even safer – especially in light of TAVR shifting to younger and lower-risk patients. The ProtEmbo System is an adjunctive device used during TAVR and removed following completion of valve implantation. The ProtEmbo is an intra-aortic filter device that is designed to deflect embolic material arising during TAVR away from the cerebral circulation.
PROTEMBIS
Social Links:
Industry:
Emergency Medicine Health Care Life Science Medical Device Personal Health
Founded:
2013-01-01
Address:
Aachen, Nordrhein-Westfalen, Germany
Country:
Germany
Website Url:
http://www.protembis.com
Total Employee:
1+
Status:
Active
Contact:
+49 (0) 241 9903 3622
Email Addresses:
[email protected]
Total Funding:
10 M USD
Technology used in webpage:
SPF LetsEncrypt IPv6 Ubuntu Smart App Banner Nextcloud Strato Strato DNS
Similar Organizations
Aulos Bioscience
Aulos Bioscience is dedicated to revolutionizing patient care in cancer with highly differentiated immuno-oncology therapeutics.
COMPASS Pathways
Compass Pathways is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health.
Enable Injections
Enable Injections designs and produces on-body delivery systems that allow patients to self-administer large amounts of medication.
Current Employees Featured
Founder
Investors List
TechVision Fonds
TechVision Fonds investment in Series A - Protembis
Abiomed
Abiomed investment in Series A - Protembis
coparion
coparion investment in Series A - Protembis
IFB Innovationsstarter
IFB Innovationsstarter investment in Seed Round - Protembis
Official Site Inspections
http://www.protembis.com
- Host name: w9e.rzone.de
- IP address: 81.169.145.158
- Location: Berlin Germany
- Latitude: 52.5174
- Longitude: 13.3985
- Timezone: Europe/Berlin
- Postal: 12529
More informations about "Protembis"
Protembis
Protembis sponsored a satellite symposium at TCT 2024, uniting renowned co-chairs, expert speakers, and panelists to discuss key topics in cerebral protection for TAVR. Learn more News 07-30-2024 . Protembis receives €20 …See details»
About – Protembis
Before co-founding Protembis he was an M&A and debt advisor. Conrad has served as Co-CEO of Protembis since 2013. Conrad graduated from the University of Mannheim and ESCP Business School where he received his …See details»
Protembis - Crunchbase Company Profile & Funding
Organization. Protembis . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Protembis is a medical device start-up company …See details»
Protembis - Org Chart, Teams, Culture & Jobs - The Org
View Protembis' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Protembis Company Profile 2024: Valuation, Funding & Investors
Protembis General Information Description. Operator of a medical device company intended to develop a minimally invasive and catheter-based filter device. The company's device …See details»
Protembis Company Profile: Overview and Full News Analysis
Protembis, an Aachen, Germany-based medical-technology company, received 20m in venture-debt financing . The company intends to use the proceeds to: complete clinical trials and …See details»
Protembis - Company Profile - Tracxn
Nov 29, 2024 Protembis - Manufacturer of cerebral protection device. Raised a total funding of $42.5M over 5 rounds from 13 investors. Founded by Conrad Rasmus and Karl Von Mangoldt …See details»
Protembis - Funding, Financials, Valuation & Investors - Crunchbase
Protembis is a medical device start-up company with its R&D base in the engineering and technology. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. ... How much …See details»
Protembis Company Profile - Office Locations, Competitors ... - Craft
Protembis is a medical device company that provides cerebral protection system solutions. It offers ProtEmbo, an adjunctive intra-aortic filter device used during transcatheter aortic valve …See details»
Protembis - EU-Startups
Aug 2, 2024 Founded in 2013, Protembis is a medical device start-up company with its R&D base in the engineering and technology city of Aachen, Germany. The company s vision is to …See details»
Protembis - Products, Competitors, Financials, Employees, …
Protembis focuses on developing medical devices for cardiac interventions, specifically targeting the reduction of neurological risks associated with these procedures. The company's main …See details»
Protembis - Devex
Learn more about Protembis's jobs, projects, latest news, contact information and geographical presence. At Protembis, they strive to develop a simple and reliable solution to protect patients ...See details»
Protembis Company Profile - MedTech Innovator
Protembis develops a novel transradial and intra-aortic cerebral protection device that minimizes stroke risk related to transcatheter aortic valve implantations (TAVI/ TAVR) and various other …See details»
Protembis Company Information - Funding, Investors, and More
The company Protembis has raised a total of $64.67m in funding over 3 rounds. Key Insights: Series A: $10m; Debt Financing: $21.67m; Series B: $33m; 2018. Protembis Series A round, …See details»
Protembis - VentureRadar
Protembis GmbH is an emerging cardiovascular medical device company known for creating the ProtEmbo® Cerebral Protection System. This intra-aortic filter device offers protection to the …See details»
First Patient Enrolled in the PROTEMBO IDE Pivotal Trial
This significant progress reflects the close collaboration between our study executive committee, our clinical research organization, and core lab partners in planning this complex trial.”, said …See details»
EU bank finances maker of ProtEmbo cerebral embolic protection …
Jul 31, 2024 The European Investment Bank (EIB)—the investment arm of the European Union (EU)—is providing €20 million in venture-debt financing to German medical-technology …See details»
Physicians – Protembis
Infarcts are associated with brain volume reduction, but importantly, also with detectably lower cognition.1 Studies show that cognitive decline relates directly to loss of brain substance with …See details»
News and Events – Protembis
Protembis Develops New Catheter-Based Filter to Protect Heart Procedure Patients from Stroke and Neurological Injuries. Learn more Load more Events. October 29, 2024, Washington DC, …See details»
Patients – Protembis
The ProtEmbo System is a new and unique device designed to protect the entire brain safely during heart procedures. Using the latest technology, the ProtEmbo is a very fine filter in the …See details»